Seeking Alpha

BiotechBull » Comments » PARD

  • Rigel Pharmaceuticals: Biotech Crisis or Opportunity? [View article]
    Big pharma company is going to fork over large $ to license rights to R788....that efficacy data (ACR scores) are the best we have seen in any pipeline drug....
    Nov 24 22:51 pm |Rating: 0 0 |Link to Comment
More on PARD by BiotechBull
Comments by Ticker
BiotechBull's
Comments Stats
4 comments
Rating: 0 (0 - 0 )